Grant Williams, MD
Dr. Grant Williams is a board-certified medical oncologist with 16 years of experience in oncology review at the FDA.
Prior to MMS, Dr. Williams was most recently Executive Director, Clinical Development at Novartis and GlaxoSmithKline (GSK).
At MMS Holdings, Dr. Williams provides consulting and advisory support in the areas of oncology clinical trial design, oncology drug regulation, preparation for regulatory meetings, scientific review of protocols, and as a Data Monitoring Committee (DMC) member. Experience within the FDA makes Dr. Williams an invaluable source of knowledge with positions that include: FDA Oncology Drugs Reviewer, FDA Oncology Drugs Team Medical Team Leader, and FDA Oncology Drugs Deputy Director.
Grant Williams, MD earned his doctorate at the University of Alabama at Birmingham (UAB) and serves on specialty boards, including Internal Medicine and Medical Oncology.